Structure of Buparlisib
CAS No.: 944396-07-0
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Buparlisib (BKM120; NVP-BKM120) is a pan-class I PI3K inhibitor with IC50 values of 52 nM for p110α, 166 nM for p110β, 116 nM for p110δ, and 262 nM for p110γ.
Synonyms: BKM120; NVP-BKM120
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 944396-07-0 |
Formula : | C18H21F3N6O2 |
M.W : | 410.39 |
SMILES Code : | NC1=NC=C(C2=CC(=NC(=N2)N2CCOCC2)N2CCOCC2)C(=C1)C(F)(F)F |
Synonyms : |
BKM120; NVP-BKM120
|
MDL No. : | MFCD18251596 |
InChI Key : | CWHUFRVAEUJCEF-UHFFFAOYSA-N |
Pubchem ID : | 16654980 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302-H315-H319-H335 |
Precautionary Statements: | P261-P305+P351+P338 |
Target |
|
In Vitro:
Concentration | Treated Time | Description | References |
HER2+/PIK3CAH1047R primary tumor cells | 1 μM | 24 h | Evaluate the effect of Buparlisib on primary tumor cells, showing upregulation of ECM gene expression | PMC5482178 |
HCC1954 cells | 1 μM | 24 h | Evaluate the effect of Buparlisib on HER2+ breast cancer cells, showing upregulation of ECM gene expression | PMC5482178 |
MDA-MB-453 cells | 0.5 µM | 48 h | Induced apoptosis | PMC7914363 |
BT20 cells | 0.5 µM | 48 h | Induced apoptosis | PMC7914363 |
MDA-MB 453 cells | 1 μM | 24 h | Evaluate the effect of Buparlisib on HER2+ breast cancer cells, showing upregulation of ECM gene expression | PMC5482178 |
H10 cells | 10 µM | 72 h | To assess the effect of Buparlisib on cell viability, results showed that Buparlisib significantly reduced cell viability. | PMC6747502 |
H3 cells | 10 µM | 72 h | To assess the effect of Buparlisib on cell viability, results showed that Buparlisib significantly reduced cell viability. | PMC6747502 |
H2 cells | 10 µM | 72 h | To assess the effect of Buparlisib on cell viability, results showed that Buparlisib significantly reduced cell viability. | PMC6747502 |
H1 cells | 10 µM | 72 h | To assess the effect of Buparlisib on cell viability, results showed that Buparlisib significantly reduced cell viability. | PMC6747502 |
WHIM12 cells | 0-1 uM | 24 h | To evaluate the cytotoxic effect of Buparlisib in combination with other drugs on WHIM12 cells, results showed synergistic anti-tumor effects. | PMC5955814 |
WHIM12 cells | 1 uM | 6 days | To evaluate the effect of Buparlisib on the growth of WHIM12 cells, results showed that Buparlisib significantly inhibited cell growth. | PMC5955814 |
C-26 tumor cells | 2.5 μM and 5 μM | 72 h | To evaluate the effect of buparlisib on the growth of C-26 tumor cells, results showed that buparlisib significantly reduced tumor growth. | PMC5292063 |
H460 cells | 1 μM | 24 h | Buparlisib reduced glucose consumption in H460 cells by inhibiting the PI3K signaling pathway. | PMC6884612 |
WHIM12 cells | 0-1 μM | To evaluate the cytotoxic effect of Buparlisib on WHIM12 cells, results showed that Buparlisib in combination with other drugs had synergistic or additive cytotoxic effects. | PMC5955814 | |
WHIM12 cells | 1 μM | 6 days | To evaluate the effect of Buparlisib on the clonogenic ability of WHIM12 cells, results showed that Buparlisib significantly inhibited colony formation. | PMC5955814 |
In Vivo:
Administration | Dosage | Frequency | Description | References |
Nude mice | HER2+/PIK3CAH1047R transgenic mammary tumor model | Oral gavage | 30 mg/kg | Once daily for over 3 weeks | Evaluate the effect of Buparlisib on HER2+/PIK3CAH1047R tumors, showing resistance to combination therapy | PMC5482178 |
Mice | TNBC cell line xenograft model | Oral | 30 mg/kg | Once daily for 7 days | Combination treatment resulted in a ~40% decrease in tumor volume after 7 days, while tumors in single agent groups showed slight growth. The combination significantly reduced lung metastatic burden. | PMC5460220 |
NOD/SCID mice | Subcutaneous H1_DL2 tumor model | Oral | 50 mg/kg | Once daily for 30 days | To assess the effect of Buparlisib on tumor growth, results showed that Buparlisib significantly inhibited tumor growth. | PMC6747502 |
Mice | PDX model | Oral | 20 mg/kg | Once daily, 5 days/week for 3 weeks | To test the growth inhibitory effect of buparlisib on PIK3R1W624R PDXs, results showed that buparlisib delayed tumor growth. | PMC7072782 |
Mice | TNBC PDX models | Oral gavage | 30mg/kg | Days 1-5 each week for 24-32 days | To evaluate the effect of Buparlisib on tumor growth in TNBC PDX models, results showed varying responsiveness across models, with some exhibiting resistance. | PMC5955814 |
NSG mice | BT20 xenograft model | Intraperitoneal injection | 25 mg/kg | Once daily for 2 weeks | Inhibited tumor growth and metastasis | PMC7914363 |
Mice | Colon-26 tumor model | Oral | 25 mg/kg | Daily for 16 days | To evaluate the effect of buparlisib on the growth of C-26 tumors, results showed that buparlisib significantly reduced tumor growth and preserved skeletal muscle mass. | PMC5292063 |
Mice | Patient-derived xenograft models of TNBC | Oral | 30 mg/kg | Days 1-5 each week for 24-32 days | To evaluate the antitumor effect of Buparlisib on PDX models, results showed significant variability in response among different models, with some models exhibiting resistance to Buparlisib. | PMC5955814 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT01820364 | Melanoma | Phase 2 | Terminated(Study was withdrawn... More >> due to scientific and business considerations.) Less << | - | United States, Tennessee ... More >> Sarah Cannon Research Institute Onc Dept Nashville, Tennessee, United States, 37203 Australia, Victoria Novartis Investigative Site East Melbourne, Victoria, Australia, 3002 Canada, Alberta Novartis Investigative Site Edmonton, Alberta, Canada, T6G 1Z2 Germany Novartis Investigative Site Heidelberg, Germany, 69120 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Switzerland Novartis Investigative Site Zuerich, Switzerland, 8091 Less << |
NCT01820364 | - | Terminated(Study was withdrawn... More >> due to scientific and business considerations.) Less << | - | - | |
NCT02159066 | Melanoma | Phase 2 | Active, not recruiting | March 30, 2019 | United States, Arizona ... More >> Mayo Clinic - Arizona onc Dept Scottsdale, Arizona, United States United States, California University of California at Los Angeles Onc Dept Los Angeles, California, United States, 90095 United States, Massachusetts Massachusetts General Hospital Dept of Onc. Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan Kettering Cancer Center Dept Oncology New York, New York, United States, 90033 United States, Oregon Oregon Health & Science University Onc. Dept Portland, Oregon, United States, 97239 United States, Tennessee Sarah Cannon Research Institute Onc. Dept Nashville, Tennessee, United States, 37203 Australia, Victoria Array BioPharma Investigative Site East Melbourne, Victoria, Australia, 3002 Canada, Ontario Array BioPharma Investigative Site Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Array BioPharma Investigative Site Montreal, Quebec, Canada, H3T 1E2 Germany Array BioPharma Investigative Site Heidelberg, Germany, 69120 Array BioPharma Investigative Site Köln, Germany, 50937 Array BioPharma Investigative Site Muenchen, Germany, 80336 Array BioPharma Investigative Site Würzburg, Germany, 97080 Italy Array BioPharma Investigative Site Napoli, Italy, 80131 Netherlands Array BioPharma Investigative Site Amsterdam, Netherlands, 1066 CX Spain Array BioPharma Investigative Site Barcelona, Catalunya, Spain, 08035 Switzerland Array BioPharma Investigative Site Zuerich, Switzerland, 8091 United Kingdom Array BioPharma Investigative Site Oxford, United Kingdom, OX3 7LJ Less << |
NCT01934361 | Recurrent Glioblastoma Multifo... More >>rme Less << | Phase 1 | Completed | - | United States, Arizona ... More >> Barrow Neurological Insitute St. Joseph's Hospital Phoenix, Arizona, United States, 85013 United States, Arkansas Highlands Oncology Group Fayetteville, Arkansas, United States, 72703 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Texas MD Anderson Cancer Center/University of Texas Houston, Texas, United States, 77030 Australia, Victoria Novartis Investigative Site Heidelberg, Victoria, Australia, 3084 Novartis Investigative Site Parkville, Victoria, Australia, 3050 Belgium Novartis Investigative Site Leuven, Belgium, 3000 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 1Z6 France Novartis Investigative Site Marseille Cedex 05, France, 13885 Novartis Investigative Site Paris Cedex 13, France, 75651 Novartis Investigative Site Saint Herblain cedex, France, 44805 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08036 Novartis Investigative Site Hospitalet de LLobregat, Catalunya, Spain, 08907 Less << |
NCT02154776 | Advanced or Metastatic Breast ... More >>Cancer Less << | Phase 1 | Completed | - | United States, California ... More >> University of California at Los Angeles UCLA SC Los Angeles, California, United States, 90095 United States, Indiana Horizon Oncology Center SC Lafayette, Indiana, United States, 47905 United States, South Carolina Medical University of South Carolina SC Charleston, South Carolina, United States, 29425 United States, Texas South Texas Accelerated Research Therapeutics SC San Antonio, Texas, United States, 78922 United States, Utah University of Utah / Huntsman Cancer Institute SC-3 Salt Lake City, Utah, United States, 84103 Spain Novartis Investigative Site Madrid, Spain, 28007 Less << |
NCT01300962 | Metastatic Breast Cancer | Phase 1 | Active, not recruiting | December 2018 | United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Less << |
NCT01132664 | Metastatic Breast Cancer ... More >> HER2+ Breast Cancer Less << | Phase 1 Phase 2 | Terminated(Due to the rare pat... More >>ient population and challenges to enroll patients.) Less << | - | United States, Alabama ... More >> University of Alabama at Birmingham/ Kirklin Clinic Univ AL - PI Birmingham, Alabama, United States, 35294-0006 United States, Arkansas Highlands Oncology Group Dept of Highlands Oncology Grp Fayetteville, Arkansas, United States, 72703 United States, Florida H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 United States, Michigan Karmanos Cancer Institute Dept.of KarmanosCancerInst (6) Detroit, Michigan, United States, 48201 United States, Missouri Washington University School Of Medicine-Siteman Cancer Ctr WA Siteman St. Louis, Missouri, United States, 63110 United States, New York Beth Israel Medical Center BIMC New York, New York, United States, 10003 United States, Tennessee Sarah Cannon Research Institute Sarah Cannon Cancer Center SC Nashville, Tennessee, United States, 37203 Belgium Novartis Investigative Site Liege, Belgium, 4000 Novartis Investigative Site Wilrijk, Belgium, 2610 France Novartis Investigative Site Lyon Cedex, France, 69373 Novartis Investigative Site Saint-Herblain Cédex, France, 44805 Italy Novartis Investigative Site Cagliari, CA, Italy, 09134 Novartis Investigative Site Macerata, MC, Italy, 62100 Novartis Investigative Site Modena, MO, Italy, 41100 Novartis Investigative Site Terni, TR, Italy, 05100 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Hospitalet de LLobregat, Catalunya, Spain, 08907 Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46010 United Kingdom Novartis Investigative Site Brighton, East Sussex, United Kingdom, BN2 5BE Novartis Investigative Site Nottingham, United Kingdom, NG5 1PB Novartis Investigative Site Oxford, United Kingdom, OX3 7LJ Less << |
NCT01132664 | - | Terminated(Due to the rare pat... More >>ient population and challenges to enroll patients.) Less << | - | - | |
NCT01285466 | Metastatic or Locally Advanced... More >> Solid Tumors Less << | Phase 1 | Completed | - | Belgium ... More >> Novartis Investigative Site Bruxelles, Belgium, 1000 Novartis Investigative Site Bruxelles, Belgium, 1200 Novartis Investigative Site Wilrijk, Belgium, 2610 Germany Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Köln, Germany, 50937 Netherlands Novartis Investigative Site Amsterdam, Netherlands, 1066 CX Spain Novartis Investigative Site Sevilla, Andalucia, Spain, 41013 Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Switzerland Novartis Investigative Site Chur, Switzerland, 7000 Novartis Investigative Site St. Gallen, Switzerland, 9007 Less << |
NCT02058381 | Pre-menopausal Breast Cancer ... More >> PI3K Pathway Inhibition Less << | Phase 1 | Completed | - | Hong Kong ... More >> Novartis Investigative Site Hong Kong, Hong Kong Korea, Republic of Novartis Investigative Site Seongnam-si, Gyeonggi-do, Korea, Republic of, 13620 Novartis Investigative Site Gyeonggi-do, Korea, Korea, Republic of, 10408 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 05505 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 06351 Novartis Investigative Site Seoul, Korea, Republic of, 03722 Taiwan Novartis Investigative Site Kuei-Shan Chiang, Taoyuan/ Taiwan ROC, Taiwan, 33305 Novartis Investigative Site New Taipei City, TWN, Taiwan, 23561 Novartis Investigative Site Kaohsiung City, Taiwan, 83301 Novartis Investigative Site Taichung, Taiwan, 407 Novartis Investigative Site Taipei, Taiwan, 10002 Novartis Investigative Site Taipei, Taiwan, 10449 Novartis Investigative Site Taipei, Taiwan, 112 Thailand Novartis Investigative Site Bangkok, Thailand, 10330 Novartis Investigative Site Chiang Mai, Thailand, 50200 Less << |
NCT01971489 | Adult Solid Neoplasm ... More >> Recurrent Non-Small Cell Lung Carcinoma Stage IIIA Non-Small Cell Lung Cancer Stage IIIB Non-Small Cell Lung Cancer Stage IV Non-Small Cell Lung Cancer Less << | Phase 1 | Withdrawn | - | United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less << |
NCT01923168 | Breast Cancer | Phase 2 | Completed | - | - |
NCT01730248 | Myelofibrosis | Phase 1 | Completed | - | Australia, Queensland ... More >> Novartis Investigative Site Herston, Queensland, Australia, 4029 Australia, Victoria Novartis Investigative Site Melbourne, Victoria, Australia, 3000 Austria Novartis Investigative Site Vienna, Austria, A-1090 France Novartis Investigative Site Paris, France, 75010 Germany Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Rostock, Germany, 18057 Israel Novartis Investigative Site Jerusalem, Israel, 91120 Novartis Investigative Site Ramat Gan, Israel, 5265601 Italy Novartis Investigative Site Firenze, FI, Italy, 50134 Novartis Investigative Site Varese, VA, Italy, 21100 Singapore Novartis Investigative Site Singapore, Singapore, 169608 Spain Novartis Investigative Site Madrid, Spain, 28041 United Kingdom Novartis Investigative Site Edgbaston, Birmingham, United Kingdom, B15 2WB Novartis Investigative Site London, United Kingdom, NW1 2BU Novartis Investigative Site London, United Kingdom, SE1 9RT Less << |
NCT02340780 | Chronic Lymphocytic Leukemia | PHASE2 | COMPLETED | 2020-04-28 | Tom Baker Cancer Centre, Calga... More >>ry, Alberta, T2N 4N2, Canada|Cross Cancer Institute, Edmonton, Alberta, T6G 1Z2, Canada|CancerCare Manitoba, Winnipeg, Manitoba, R3E 0V9, Canada|QEII Health Sciences Centre, Halifax, Nova Scotia, B3H 1V7, Canada|University Health Network, Toronto, Ontario, M5G 2M9, Canada|The Jewish General Hospital, Montreal, Quebec, H3T 1E2, Canada Less << |
NCT01923168 | - | Completed | - | - | |
NCT02303041 | Basal Cell Carcinoma (BCC) of ... More >>the Skin Nevoid Basal Cell Carcinoma (BCC) Syndrome Recurrent Skin Cancer Less << | Phase 2 | Completed | - | United States, California ... More >> Stanford University, School of Medicine Stanford, California, United States, 94305 Less << |
NCT02088684 | Breast Cancer | Phase 1 Phase 2 | Completed | - | United States, Alabama ... More >> University of Alabama at Birmingham/ Kirklin Clinic Dept Onc Birmingham, Alabama, United States, 35294-0006 United States, Massachusetts Dana Farber Cancer Institute Onc. Dept. Boston, Massachusetts, United States, 02215 United States, Tennessee Sarah Cannon Research Institute Onc Dept Nashville, Tennessee, United States, 37203 France Novartis Investigative Site Lyon Cedex, France, 69373 Italy Novartis Investigative Site Milano, MI, Italy, 20132 Novartis Investigative Site Modena, MO, Italy, 41124 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 06351 Singapore Novartis Investigative Site Singapore, Singapore, 119228 Spain Novartis Investigative Site Madrid, Spain, 28050 Taiwan Novartis Investigative Site Taipei, Taiwan ROC, Taiwan, 10041 United Kingdom Novartis Investigative Site Leicester, United Kingdom, LE1 5WW Less << |
NCT01727128 | Hepatic Impairment | PHASE1 | COMPLETED | 2025-08-13 | Novartis Investigative Site, S... More >>ofia, 1618, Bulgaria|Novartis Investigative Site, Berlin, 14050, Germany|Novartis Investigative Site, Moscow, 117198, Russian Federation Less << |
NCT02756247 | Lymphoma Mant... More >>le Cell Lymphoma Follicular Lymphoma Diffuse Large B Cell Lymphoma Less << | Phase 1 | Active, not recruiting | May 2019 | United States, New Jersey ... More >> Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States, 07920 Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States, 07748 United States, New York Memorial Sloan Kettering Commack Commack, New York, United States, 11725 Memorial Sloan Kettering Westchester Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering Rockville Centre Rockville Centre, New York, United States, 11570 Less << |
NCT02117817 | Ovarian Cancer ... More >> Endometrial Cancer Recurrent Ovarian Cancer Recurrent Endometrial Cancer Less << | Phase 1 | Withdrawn(Research cancelled) | - | - |
NCT02452294 | Malignant Melanoma|Metastases | PHASE2 | UNKNOWN | 2025-07-18 | Department of Dermatology, Uni... More >>versity Hopsital, Dresden, 01307, Germany|Department of Dermatology, University Hospital, Tuebingen, 72076, Germany Less << |
NCT01397877 | Endometrial Cancer | PHASE2 | COMPLETED | 2025-03-16 | Clinique Bonnefon, Ales, Franc... More >>e|Centre Paul Papin, Angers, France|Institut Ste Catherine, Avignon, France|H?pital jean Minjoz, Besancon, France|Centre Hospitalier de Blois, Blois, France|Clinique Tivoli, Bordeaux, France|Institut Bergonié, Bordeaux, France|Polyclinique Bordeaux Nord, Bordeaux, France|centre Francois baclesse, Caen, France|Centre jean Perrin, Clermont Ferrand, France|H?pitaux Civils de Colmar, Colmar, France|Centre Georges Fran?ois leclerc, Dijon, France|Group Hospitalier Mutualiste de Grenoble, Grenoble, France|H?pital Michallon - CHU Grenoble, Grenoble, France|CHD Les Oudairies, la Roche sur Yon, France|H?pital André Mignot, Le Chesnay, France|Centre jean Bernard, Le Mans, France|Centre Oscar Lambret, Lille, France|CHU Dupuytren, Limoges, France|Centre Léon bérard, Lyon, France|H?pital Prové Clairval, Marseille, France|institut Paoli Calmette, Marseille, France|CRLC Val d'Aurelle, Montpellier, 34298, France|Groupement de coopération sanitaire, Montpellier, France|Centre Alexis Vautrin, Nancy, France|Centre d'oncologie de Gentilly, Nancy, France|Centre Catherine de Sienne, Nantes, France|Centre Antoine Lacassagne, Nice, France|CHU Caremeau, Nimes, France|Clinique Valdegour, Nimes, France|Centre Hospitalier Régional, Orléans, France|Hopital Hotel Dieu, Paris, 75004, France|Hopital Tenon, Paris, 75020, France|Centre Eugene Marquis, Rennes, France|Centre Frederic Joliot, Rouen, France|Centre Henri Becquerel, Rouen, France|Clinique Armoricaine de Radiologie, Saint Brieuc, France|H?pital rené Huguenin, St Cloud, France|ICO René Gauducheau, St Herblain, France|Centre Etienne DOLET, St Nazaire, France|Institut cancérologuie de la loire, St Priest en Jarez, France|H?pital Civil, Strasbourg, France|Centre Claudius Régaud, Toulouse, 31052, France|CHU Bretonneau, Tours, France|Institut Gustave Roussy, Villejuif, France Less << |
NCT01816984 | Metastatic Squamous Neck Cance... More >>r With Occult Primary Squamous Cell Carcinoma Recurrent Metastatic Squamous Neck Cancer With Occult Primary Recurrent Salivary Gland Cancer Recurrent Squamous Cell Carcinoma of the Hypopharynx Recurrent Squamous Cell Carcinoma of the Larynx Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity Recurrent Squamous Cell Carcinoma of the Nasopharynx Recurrent Squamous Cell Carcinoma of the Oropharynx Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Recurrent Verrucous Carcinoma of the Larynx Recurrent Verrucous Carcinoma of the Oral Cavity Salivary Gland Squamous Cell Carcinoma Stage IV Squamous Cell Carcinoma of the Hypopharynx Stage IV Squamous Cell Carcinoma of the Nasopharynx Stage IVA Salivary Gland Cancer Stage IVA Squamous Cell Carcinoma of the Larynx Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IVA Squamous Cell Carcinoma of the Oropharynx Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVA Verrucous Carcinoma of the Larynx Stage IVA Verrucous Carcinoma of the Oral Cavity Stage IVB Salivary Gland Cancer Stage IVB Squamous Cell Carcinoma of the Larynx Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IVB Squamous Cell Carcinoma of the Oropharynx Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVB Verrucous Carcinoma of the Larynx Stage IVB Verrucous Carcinoma of the Oral Cavity Stage IVC Salivary Gland Cancer Stage IVC Squamous Cell Carcinoma of the Larynx Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IVC Squamous Cell Carcinoma of the Oropharynx Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVC Verrucous Carcinoma of the Larynx Stage IVC Verrucous Carcinoma of the Oral Cavity Tongue Cancer Less << | Phase 1 Phase 2 | Active, not recruiting | June 2018 | United States, Illinois ... More >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637-1470 Less << |
NCT01551030 | Metastatic Transitional Cell C... More >>arcinoma of the Urothelium Less << | PHASE2 | COMPLETED | 2020-09-02 | Memorial Sloan-Kettering at Ba... More >>sking Ridge, Basking Ridge, New Jersey, 07920, United States|Memorial Sloan-Kettering Cancer Center @ Suffolk, Commack, New York, 11725, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Memorial Sloan-Kettering Cancer Center at Mercy Medical Center, Rockville Centre, New York, 11570, United States|Memoral Sloan Kettering Cancer Center@Phelps, Sleepy Hollow, New York, United States Less << |
NCT01816594 | HER2-positive, Newly Diagnosed... More >>, Primary Breast Cancer, Neoadjuvant Therapy, Trastuzumab Less << | Phase 2 | Completed | - | Australia, New South Wales ... More >> Novartis Investigative Site Concord NSW, New South Wales, Australia, 2139 Australia, Victoria Novartis Investigative Site Parkville, Victoria, Australia, 3050 Austria Novartis Investigative Site Salzburg, Austria, 5020 Germany Novartis Investigative Site Düsseldorf, Nordrhein Westfalen, Germany, 40235 Novartis Investigative Site Berlin, Germany, 13125 Novartis Investigative Site Dortmund, Germany, 44137 Novartis Investigative Site Erlangen, Germany, 91054 Novartis Investigative Site Essen, Germany, 45043 Novartis Investigative Site Essen, Germany, 45122 Novartis Investigative Site Gera, Germany, 07548 Novartis Investigative Site Kiel, Germany, 24105 Novartis Investigative Site Lübeck, Germany, 23538 Novartis Investigative Site Muenster, Germany, 48149 Novartis Investigative Site Offenbach, Germany, 63069 Singapore Novartis Investigative Site Singapore, Singapore, 119228 Spain Novartis Investigative Site Sevilla, Andalucia, Spain, 4103 Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46010 Novartis Investigative Site Majadahonda, Madrid, Spain, 28222 Novartis Investigative Site Reus, Tarragona, Spain, 43204 Less << |
NCT02048787 | Renal Impairment | PHASE1 | COMPLETED | 2025-03-15 | Novartis Investigative Site, S... More >>ofia, 1612, Bulgaria|Novartis Investigative Site, Praha 4, 140 59, Czechia|Novartis Investigative Site, Berlin, 14050, Germany|Novartis Investigative Site, Bucuresti, Romania Less << |
NCT01248494 | Metastatic Breast Cancer | Phase 1 | Completed | - | United States, Alabama ... More >> University of Alabama Birmingham, Alabama, United States United States, Massachusetts Massachusetts General Hospital, Dana Farber Cancer Center Boston, Massachusetts, United States, 02114 United States, New York Columbia University Medical Center New York City, New York, United States United States, Tennessee Vanderbilt Cool Springs Nashville, Tennessee, United States, 37067 Vanderbilt Breast Center One Hundred Oaks Nashville, Tennessee, United States, 37204 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 Less << |
NCT01719250 | Recurrent Adult Diffuse Large ... More >>Cell Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Refractory Mantle Cell Lymphoma Transformed Recurrent Non-Hodgkin Lymphoma Less << | Early Phase 1 | Completed | - | United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less << |
NCT01512251 | BRAF Mutant Metastatic Melanom... More >>a Less << | Phase 1 Phase 2 | Completed | - | United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94115 Less << |
NCT01363232 | Advanced Solid Tumors ... More >> Selected Solid Tumors Less << | Phase 1 | Completed | - | United States, Massachusetts ... More >> Massachusetts General Hospital Mass General 2 Boston, Massachusetts, United States, 02115 United States, Michigan Karmanos Cancer Institute Study Coordinator Detroit, Michigan, United States, 48201 United States, New York Memorial Sloan Kettering Cancer Center MSKCC (2) New York, New York, United States, 90033 United States, South Carolina Cancer Centers of the Carolinas CCC Faris Greenville, South Carolina, United States, 29605 United States, Texas University of Texas/MD Anderson Cancer Center MD Anderson PSC Houston, Texas, United States, 77030-4009 Canada, Ontario Array BioPharma Investigative Site Toronto, Ontario, Canada, M5G 2M9 Germany Array BioPharma Investigative Site Essen, Germany, 45147 Array BioPharma Investigative Site Heidelberg, Germany, 69120 Netherlands Array BioPharma Investigative Site Utrecht, Netherlands, 3584CX Singapore Array BioPharma Investigative Site Singapore, Singapore, 169610 Spain Array BioPharma Investigative Site Barcelona, Catalunya, Spain, 08035 Switzerland Array BioPharma Investigative Site Bellinzona, Switzerland, 6500 Less << |
NCT01155453 | Advanced and Selected Solid Tu... More >>mors Less << | Phase 1 | Completed | - | United States, California ... More >> University of California at Los Angeles Div. of Hematology/Oncology Los Angeles, California, United States, 90095 United States, Texas University of Texas/MD Anderson Cancer Center Dept of MD Anderson (8) Houston, Texas, United States, 77030-4009 Belgium Novartis Investigative Site Leuven, Belgium, 3000 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 2M9 Spain Novartis Investigative Site Sevilla, Andalucia, Spain, 41013 Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Switzerland Novartis Investigative Site Bellinzona, Switzerland, 6500 Less << |
NCT01512251 | - | Completed | - | - | |
NCT02614508 | Recurrent Chronic Lymphocytic ... More >>Leukemia Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Small Lymphocytic Lymphoma Less << | Phase 1 | Active, not recruiting | October 2022 | United States, Georgia ... More >> Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less << |
NCT01283503 | Advanced Solid Tumor | PHASE1 | COMPLETED | 2025-10-11 | Novartis Investigative Site, N... More >>agoya-city, Aichi, 466-8560, Japan|Novartis Investigative Site, Kashiwa, Chiba, 277-8577, Japan Less << |
NCT01693614 | Diffuse Large B-cell Lymphoma,... More >> Mantle Cell Lymphoma, Follicular Lymphoma Less << | PHASE2 | COMPLETED | 2017-07-21 | Massachusetts General Hospital... More >>, Boston, Massachusetts, 02114, United States|University of Nebraska Medical Center Univ Nebraska, Omaha, Nebraska, 68198, United States|Memorial Sloan Kettering Dept of Onc., New York, New York, 10017, United States|Medical University of South Carolina -Hollings Cancer Center Medical Univ of South Carolina, Charleston, South Carolina, 29425, United States|University of Texas MD Anderson Cancer Center Dept.ofMDAndersonCancerCtr(3), Houston, Texas, 77030, United States|Novartis Investigative Site, Brugge, 8000, Belgium|Novartis Investigative Site, Yvoir, 5530, Belgium|Novartis Investigative Site, Marseille, 13273, France|Novartis Investigative Site, Pierre-Benite Cedex, 69495, France|Novartis Investigative Site, Rennes, 35019, France|Novartis Investigative Site, Frankfurt, 60590, Germany|Novartis Investigative Site, Wurzburg, 97080, Germany|Novartis Investigative Site, Milano, MI, 20133, Italy|Novartis Investigative Site, Milano, MI, 20141, Italy|Novartis Investigative Site, Gyeonggi-do, Korea, 10408, Korea, Republic of|Novartis Investigative Site, Seoul, Korea, 06351, Korea, Republic of|Novartis Investigative Site, Salamanca, Castilla Y Leon, 37007, Spain|Novartis Investigative Site, Hospitalet de LLobregat, Catalunya, 08907, Spain|Novartis Investigative Site, Izmir, 35040, Turkey|Novartis Investigative Site, Samsun, 55139, Turkey Less << |
NCT01693614 | Diffuse Large B-cell Lymphoma,... More >> Mantle Cell Lymphoma, Follicular Lymphoma Less << | PHASE2 | COMPLETED | 2017-07-21 | Massachusetts General Hospital... More >>, Boston, Massachusetts, 02114, United States|University of Nebraska Medical Center Univ Nebraska, Omaha, Nebraska, 68198, United States|Memorial Sloan Kettering Dept of Onc., New York, New York, 10017, United States|Medical University of South Carolina -Hollings Cancer Center Medical Univ of South Carolina, Charleston, South Carolina, 29425, United States|University of Texas MD Anderson Cancer Center Dept.ofMDAndersonCancerCtr(3), Houston, Texas, 77030, United States|Novartis Investigative Site, Brugge, 8000, Belgium|Novartis Investigative Site, Yvoir, 5530, Belgium|Novartis Investigative Site, Marseille, 13273, France|Novartis Investigative Site, Pierre-Benite Cedex, 69495, France|Novartis Investigative Site, Rennes, 35019, France|Novartis Investigative Site, Frankfurt, 60590, Germany|Novartis Investigative Site, Wurzburg, 97080, Germany|Novartis Investigative Site, Milano, MI, 20133, Italy|Novartis Investigative Site, Milano, MI, 20141, Italy|Novartis Investigative Site, Gyeonggi-do, Korea, 10408, Korea, Republic of|Novartis Investigative Site, Seoul, Korea, 06351, Korea, Republic of|Novartis Investigative Site, Salamanca, Castilla Y Leon, 37007, Spain|Novartis Investigative Site, Hospitalet de LLobregat, Catalunya, 08907, Spain|Novartis Investigative Site, Izmir, 35040, Turkey|Novartis Investigative Site, Samsun, 55139, Turkey Less << |
NCT01289041 | Advanced Endometrial Cancer | PHASE2 | COMPLETED | 2025-03-14 | St. Joseph's Hospital & Medica... More >>l Center St Joseph's, Phoenix, Arizona, 85013, United States|Highlands Oncology Group Dept of Highlands Oncology Grp, Fayetteville, Arkansas, 72703, United States|Morristown Memorial Hospital MMH, Morristown, New Jersey, 07962, United States|Carolinas HealthCare Systems Blumenthal Cancer Center, Charlotte, North Carolina, 28207, United States|University of Oklahoma Health Sciences Center OU Health, Oklahoma City, Oklahoma, 73104, United States|Sarah Cannon Research Institute SCRI (2), Nashville, Tennessee, 37203, United States|Texas Oncology, P.A. Austin, Bedford, Texas, 76022, United States|South Texas Oncology and Hematology, PA South Tex Onc, San Antonio, Texas, 78258, United States|Cancer Care Northwest CC Northwest- Spokane South(3), Spokane, Washington, 99202, United States|Novartis Investigative Site, Parkville, Victoria, 3050, Australia|Novartis Investigative Site, Leuven, 3000, Belgium|Novartis Investigative Site, Liege, 4000, Belgium|Novartis Investigative Site, Wilrijk, 2610, Belgium|Novartis Investigative Site, Rio de Janeiro, RJ, 20220410, Brazil|Novartis Investigative Site, Vancouver, British Columbia, V5Z 4E6, Canada|Novartis Investigative Site, Hamilton, Ontario, L8V 5C2, Canada|Novartis Investigative Site, Toronto, Ontario, M5G 2M9, Canada|Novartis Investigative Site, Montreal, Quebec, H2L 4M1, Canada|Novartis Investigative Site, Le Mans Cedex, 72015, France|Novartis Investigative Site, Lyon Cedex, 69373, France|Novartis Investigative Site, Nice Cedex 2, 06189, France|Novartis Investigative Site, Toulouse Cedex 9, 31059, France|Novartis Investigative Site, Berlin, 10367, Germany|Novartis Investigative Site, Berlin, 13353, Germany|Novartis Investigative Site, K?ln, 50937, Germany|Novartis Investigative Site, Mainz, 55131, Germany|Novartis Investigative Site, Milano, MI, 20141, Italy|Novartis Investigative Site, Aviano, PN, 33081, Italy|Novartis Investigative Site, Roma, RM, 00168, Italy|Novartis Investigative Site, Bologna, 40138, Italy|Novartis Investigative Site, Napoli, 80131, Italy|Novartis Investigative Site, Nagoya, Aichi, 464-8681, Japan|Novartis Investigative Site, Chuo-ku, Tokyo, 104-0045, Japan|Novartis Investigative Site, Minato-ku, Tokyo, 105-8471, Japan|Novartis Investigative Site, Warszawa, 00973, Poland|Novartis Investigative Site, St. Petersburg, 198255, Russian Federation|Novartis Investigative Site, Singapore, 229899, Singapore|Novartis Investigative Site, Barcelona, Catalunya, 08036, Spain|Novartis Investigative Site, Valencia, Comunidad Valenciana, 46009, Spain|Novartis Investigative Site, Valencia, Comunidad Valenciana, 46026, Spain|Novartis Investigative Site, Madrid, 28033, Spain|Novartis Investigative Site, Madrid, 28046, Spain Less << |
NCT02220855 | Thymoma | PHASE2 | COMPLETED | 2021-03-09 | Indiana University Simon Cance... More >>r Center, Indianapolis, Indiana, 46202, United States Less << |
NCT01501604 | Lung Cancer|Breast Cancer|Colo... More >>rectal Cancer|Cholangiocarcinoma|Solid Tumors Less << | PHASE2 | WITHDRAWN | 2025-08-13 | - |
NCT01610284 | Breast Cancer | Phase 3 | Active, not recruiting | December 31, 2018 | - |
NCT01723800 | Recurrent Non-small Cell Lung ... More >>Cancer Stage IV Non-small Cell Lung Cancer Less << | Phase 1 | Completed | - | United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 Less << |
NCT01540253 | Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << | Phase 1 | Completed | - | United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less << |
NCT01289041 | Advanced Endometrial Cancer | PHASE2 | COMPLETED | 2025-03-14 | St. Joseph's Hospital & Medica... More >>l Center St Joseph's, Phoenix, Arizona, 85013, United States|Highlands Oncology Group Dept of Highlands Oncology Grp, Fayetteville, Arkansas, 72703, United States|Morristown Memorial Hospital MMH, Morristown, New Jersey, 07962, United States|Carolinas HealthCare Systems Blumenthal Cancer Center, Charlotte, North Carolina, 28207, United States|University of Oklahoma Health Sciences Center OU Health, Oklahoma City, Oklahoma, 73104, United States|Sarah Cannon Research Institute SCRI (2), Nashville, Tennessee, 37203, United States|Texas Oncology, P.A. Austin, Bedford, Texas, 76022, United States|South Texas Oncology and Hematology, PA South Tex Onc, San Antonio, Texas, 78258, United States|Cancer Care Northwest CC Northwest- Spokane South(3), Spokane, Washington, 99202, United States|Novartis Investigative Site, Parkville, Victoria, 3050, Australia|Novartis Investigative Site, Leuven, 3000, Belgium|Novartis Investigative Site, Liege, 4000, Belgium|Novartis Investigative Site, Wilrijk, 2610, Belgium|Novartis Investigative Site, Rio de Janeiro, RJ, 20220410, Brazil|Novartis Investigative Site, Vancouver, British Columbia, V5Z 4E6, Canada|Novartis Investigative Site, Hamilton, Ontario, L8V 5C2, Canada|Novartis Investigative Site, Toronto, Ontario, M5G 2M9, Canada|Novartis Investigative Site, Montreal, Quebec, H2L 4M1, Canada|Novartis Investigative Site, Le Mans Cedex, 72015, France|Novartis Investigative Site, Lyon Cedex, 69373, France|Novartis Investigative Site, Nice Cedex 2, 06189, France|Novartis Investigative Site, Toulouse Cedex 9, 31059, France|Novartis Investigative Site, Berlin, 10367, Germany|Novartis Investigative Site, Berlin, 13353, Germany|Novartis Investigative Site, K?ln, 50937, Germany|Novartis Investigative Site, Mainz, 55131, Germany|Novartis Investigative Site, Milano, MI, 20141, Italy|Novartis Investigative Site, Aviano, PN, 33081, Italy|Novartis Investigative Site, Roma, RM, 00168, Italy|Novartis Investigative Site, Bologna, 40138, Italy|Novartis Investigative Site, Napoli, 80131, Italy|Novartis Investigative Site, Nagoya, Aichi, 464-8681, Japan|Novartis Investigative Site, Chuo-ku, Tokyo, 104-0045, Japan|Novartis Investigative Site, Minato-ku, Tokyo, 105-8471, Japan|Novartis Investigative Site, Warszawa, 00973, Poland|Novartis Investigative Site, St. Petersburg, 198255, Russian Federation|Novartis Investigative Site, Singapore, 229899, Singapore|Novartis Investigative Site, Barcelona, Catalunya, 08036, Spain|Novartis Investigative Site, Valencia, Comunidad Valenciana, 46009, Spain|Novartis Investigative Site, Valencia, Comunidad Valenciana, 46026, Spain|Novartis Investigative Site, Madrid, 28033, Spain|Novartis Investigative Site, Madrid, 28046, Spain Less << |
NCT01911325 | Squamous Non-small Cell Lung C... More >>ancer Less << | Phase 1 | Terminated(Review of safety an... More >>d preliminary efficacy data showed marginal anti-tumor activity.) Less << | - | United States, Arkansas ... More >> Highlands Oncology Group SC-1 Fayetteville, Arkansas, United States, 72703 United States, Florida H. Lee Moffitt Cancer Center & Research Institute H Lee Moffitt Tampa, Florida, United States, 33612 United States, Massachusetts Reliant Medical Group Reliant Medical Group Worcester, Massachusetts, United States, 01608 United States, Virginia Virginia Oncology Associates Virginia Oncology Assoc. (2) Norfolk, Virginia, United States, 23502 Belgium Novartis Investigative Site Charleroi, Belgium, 6000 Novartis Investigative Site Mons, Belgium, 7000 France Novartis Investigative Site Creteil, France, 94000 Novartis Investigative Site Saint Herblain cedex, France, 44805 Germany Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Mainz, Germany, 55131 Italy Novartis Investigative Site Monza, MB, Italy, 20900 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 05505 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 06351 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08036 Sweden Novartis Investigative Site Stockholm, Sweden, 171 76 Less << |
NCT01626209 | Advanced Breast Cancer, Advanc... More >>ed Carcinomas With Squamous Cell Histology Less << | PHASE1 | COMPLETED | 2025-04-14 | Novartis Investigative Site, G... More >>uangzhou, Guangdong, 510030, China|Novartis Investigative Site, Beijing, 100021, China|Novartis Investigative Site, Guangzhou, 510060, China Less << |
NCT01633060 | Metastatic Breast Cancer | Phase 3 | Completed | - | - |
NCT02049541 | Extranodal Marginal Zone B-cel... More >>l Lymphoma of Mucosa-associated Lymphoid Tissue Nodal Marginal Zone B-cell Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Splenic Marginal Zone Lymphoma Waldenstr?m Macroglobulinemia Less << | Phase 1 | Active, not recruiting | December 31, 2018 | United States, Georgia ... More >> Emory University Atlanta, Georgia, United States, 30322 United States, Ohio Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less << |
NCT01339442 | Estrogen Receptor-positive Bre... More >>ast Cancer Recurrent Breast Cancer Stage IV Breast Cancer Less << | Phase 1 | Completed | - | United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less << |
NCT01741753 | Prostate Cancer | Phase 1 | Terminated(Due to slow accrual... More >> the supllier of BKM120 requested that we cease further enrollment.) Less << | - | United States, Massachusetts ... More >> Beth-Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less << |
NCT01576666 | Dose Escalation ... More >> Safety Preliminary Efficacy Advanced Solid Tumors Metastatic Breast Cancer Advanced Pancreatic Adenocarcinoma Metastatic Colorectal Cancer Recurrent Glioblastoma Multiforme Gastric Cancer Gastroesophageal Junction Cancer Triple Negative Metastatic Breast Cancer Hormone Receptor Positive (ER+/PR+, and Her2-) Metastatic Breast Cancer Less << | Phase 1 | Completed | - | - |
NCT01572727 | Breast Cancer | Phase 2 Phase 3 | Completed | - | - |
NCT01572727 | - | Completed | - | - | |
NCT01470209 | Solid Tumors ... More >>Lung Cancer Less << | Phase 1 | Completed | - | United States, Georgia ... More >> Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 Less << |
NCT01820325 | Non-Small Cell Lunch Cancer | Phase 1 | Terminated(Due to DLTs/AEs saf... More >>ety profile considered challenging.) Less << | - | United States, Arkansas ... More >> Highlands Oncology Group Fayetteville, Arkansas, United States, 72703 United States, Oregon Northwest Cancer Specialists Compass Oncology -BKM Portland, Oregon, United States, 97210 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 1Z6 Germany Novartis Investigative Site Ulm, Germany, 89081 Italy Novartis Investigative Site Napoli, Italy, 80131 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Madrid, Spain, 28046 Less << |
NCT01068483 | Breast Cancer|Colon Cancer|Ova... More >>rian Cancer|Endometrium Cancer Less << | PHASE1 | COMPLETED | 2025-08-12 | Sarah Cannon Research Institut... More >>e Dept.ofSarahCannonCancerCtr(4), Nashville, Tennessee, 37203, United States|Novartis Investigative Site, Toronto, Ontario, M5G 2M9, Canada|Novartis Investigative Site, Rotterdam, 3015 CE, Netherlands|Novartis Investigative Site, Rotterdam, 3075 EA, Netherlands|Novartis Investigative Site, Barcelona, Cataluna, 08035, Spain Less << |
NCT01339052 | Glioblastoma | Phase 2 | Active, not recruiting | August 2018 | United States, California ... More >> University of California, Los Angeles Los Angeles, California, United States, 90095 University of California, San Francisco San Francisco, California, United States, 94143 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Texas UT, MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Utah Huntsman Cancer Institute, University of Utah Salt Lake City, Utah, United States, 84112 Less << |
NCT01339052 | - | Active, not recruiting | - | - | |
NCT01297491 | Non-small Cell Lung Cancer | PHASE2 | COMPLETED | 2025-10-14 | Ironwood Cancer and Research C... More >>enters SC, Chandler, Arizona, 85224, United States|Arizona Oncology Associates Tucson (Rudasill & La Cholla), Phoenix, Arizona, United States|Mayo Clinic - Arizona Mayo Scottsdale AZ, Scottsdale, Arizona, 85259, United States|Highlands Oncology Group Dept of Highlands Oncology Grp, Fayetteville, Arkansas, 72753, United States|Cedars Sinai Medical Center Dept.of Cedars-Sinai Med. Ctr., Los Angeles, California, 90048, United States|University of California at San Diego, Moores Cancer Ctr SC, San Diego, California, 92103, United States|University of Colorado Univ CO, Aurora, Colorado, 80045, United States|Rocky Mountain Cancer Centers Dept. of Rocky Mountain Cancer, Greenwood Village, Colorado, 80218, United States|H. Lee Moffitt Cancer Center & Research Institute H Lee Moffitt, Tampa, Florida, 33612, United States|Emory University School of Medicine/Winship Cancer Institute Emory 2, Atlanta, Georgia, 30322, United States|Rush University Medical Center SC, Chicago, Illinois, 60612, United States|University of Chicago Medical Center Unvi Chi, Chicago, Illinois, 60637, United States|University of Kansas Cancer Center Univ of KS, Kansas City, Kansas, 66160, United States|Massachusetts General Hospital Mass General, Boston, Massachusetts, 02114, United States|Fallon Clinic at Worcester Medical Center Fallon Clinic Worcester Med, Worcester, Massachusetts, 01608, United States|Karmanos Cancer Institute Wayne St Karmanos, Detroit, Michigan, 48201, United States|Washington University School of Medicine Washington University (16), St. Louis, Missouri, 63110, United States|Hematology Oncology Associates of Northern New Jersey PA DeptofHem-OncofNorthern NJ (2), Morristown, New Jersey, 07962, United States|Overlook Hospital - Carol G Simon Cancer Center Carol G Simon, Summit, New Jersey, 07901, United States|Roswell Park Cancer Institute Rosewell, Buffalo, New York, 14263, United States|Memorial Sloan Kettering Cancer Center Sloan Kettering, NY, New York, 90033, United States|Duke University Medical Center Duke 2, Durham, North Carolina, 27710, United States|MetroHealth Medical Center Dept.ofMetroHealthMedCtr.(2), Cleveland, Ohio, 44109-1998, United States|University of Oklahoma Health Sciences Center Dept. of Oklahoma Univ. HSC, Oklahoma City, Oklahoma, 73104, United States|Northwest Cancer Specialists Compass Oncology -BKM, Portland, Oregon, 97210, United States|University of Pittsburgh Medical Center SC-2, Pittsburgh, Pennsylvania, 15213, United States|Medical University of South Carolina MUSC, Charleston, South Carolina, 29425, United States|Baylor Health Care System/Sammons Cancer Center Baylor Texas Oncology, Dallas, Texas, 75246, United States|Texas Oncology South Texas Oncology, Dallas, Texas, 75251, United States|U of TX Southwestern Medical Center - SimmonsCompCancerCtr Clinical Research Office, Dallas, Texas, 75390-9151, United States|Virginia Oncology Associates VOA - Lake Wright (2), *see Various Departments*, Virginia, 23502, United States|University of Wisconsin Univ WIsc 2, Madison, Wisconsin, 53792, United States|Novartis Investigative Site, Rio Negro, Viedma, 8500, Argentina|Novartis Investigative Site, Buenos Aires, C1050AAK, Argentina|Novartis Investigative Site, Cordoba, X5002AOQ, Argentina|Novartis Investigative Site, Brussel, 1090, Belgium|Novartis Investigative Site, Charleroi, 6000, Belgium|Novartis Investigative Site, Genk, 3600, Belgium|Novartis Investigative Site, Leuven, 3000, Belgium|Novartis Investigative Site, Libramont, 6800, Belgium|Novartis Investigative Site, Salvador, BA, 41253-190, Brazil|Novartis Investigative Site, Rio de Janeiro, RJ, 20230-130, Brazil|Novartis Investigative Site, Florianopolis, SC, 88034-000, Brazil|Novartis Investigative Site, Barretos, SP, 14784-400, Brazil|Novartis Investigative Site, S?o Paulo, SP, 01246-000, Brazil|Novartis Investigative Site, Vancouver, British Columbia, V5Z 4E6, Canada|Novartis Investigative Site, Toronto, Ontario, M5G 1Z5, Canada|Novartis Investigative Site, Montreal, Quebec, H2X 3J4, Canada|Novartis Investigative Site, Caen Cedex, 14021, France|Novartis Investigative Site, Creteil, 94000, France|Novartis Investigative Site, Marseille cedex 20, 13915, France|Novartis Investigative Site, Rennes, F-35043, France|Novartis Investigative Site, Villejuif Cedex, 94805, France|Novartis Investigative Site, Berlin, 13125, Germany|Novartis Investigative Site, Essen, 45147, Germany|Novartis Investigative Site, Gauting, 82131, Germany|Novartis Investigative Site, Grosshansdorf, 22927, Germany|Novartis Investigative Site, Heidelberg, 69120, Germany|Novartis Investigative Site, Koeln, 51109, Germany|Novartis Investigative Site, Nuernberg, 90419, Germany|Novartis Investigative Site, Oldenburg, 26121, Germany|Novartis Investigative Site, Recklinghausen, 45657, Germany|Novartis Investigative Site, Hongkong, Hong Kong|Novartis Investigative Site, Budapest, 1121, Hungary|Novartis Investigative Site, Budapest, 1125, Hungary|Novartis Investigative Site, Deszk, 6772, Hungary|Novartis Investigative Site, Mátraháza, 3233, Hungary|Novartis Investigative Site, Szolnok, H-5000, Hungary|Novartis Investigative Site, Avellino, AV, 83100, Italy|Novartis Investigative Site, Genova, GE, 16132, Italy|Novartis Investigative Site, Milano, MI, 20133, Italy|Novartis Investigative Site, Milano, MI, 20141, Italy|Novartis Investigative Site, Parma, PR, 43100, Italy|Novartis Investigative Site, Udine, UD, 33100, Italy|Novartis Investigative Site, Kurashiki, Okayama, 710-8602, Japan|Novartis Investigative Site, Koto, Tokyo, 135-8550, Japan|Novartis Investigative Site, Maastricht, 6229 HX, Netherlands|Novartis Investigative Site, Singapore, 169610, Singapore|Novartis Investigative Site, Sabadell, Barcelona, 08208, Spain|Novartis Investigative Site, Barcelona, Catalunya, 08035, Spain|Novartis Investigative Site, Mataro, Catalu?a, 08301, Spain|Novartis Investigative Site, Alicante, Comunidad Valenciana, 03010, Spain|Novartis Investigative Site, Tainan 704, Taiwan ROC, 704, Taiwan|Novartis Investigative Site, Taipei, Taiwan ROC, 100, Taiwan|Novartis Investigative Site, Bangkok, 10700, Thailand|Novartis Investigative Site, Chiang Mai, 50200, Thailand|Novartis Investigative Site, Altunizade, 34662, Turkey|Novartis Investigative Site, Izmir, 35040, Turkey|Novartis Investigative Site, Northwood, Middlesex, HA6 2RN, United Kingdom|Novartis Investigative Site, Leicester, LE1 5WW, United Kingdom|Novartis Investigative Site, London, SE1 9RT, United Kingdom|Novartis Investigative Site, Manchester, M20 4BX, United Kingdom Less << |
NCT01468688 | 3rd Line GIST | Phase 1 | Completed | - | United States, Massachusetts ... More >> Dana Farber Cancer Institute SC (2) Boston, Massachusetts, United States, 02215 United States, Washington Seattle Cancer Care Alliance Onc Seattle, Washington, United States, 98105 Belgium Novartis Investigative Site Leuven, Belgium, 3000 Canada, British Columbia Novartis Investigative Site Vancouver, British Columbia, Canada, V5Z 4E6 France Novartis Investigative Site Lyon Cedex, France, 69373 Novartis Investigative Site Villejuif Cedex, France, 94805 Japan Novartis Investigative Site Kashiwa, Chiba, Japan, 277-8577 Netherlands Novartis Investigative Site Leiden, Netherlands, 2300 RC Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 United Kingdom Novartis Investigative Site London, United Kingdom, SW3 6JJ Novartis Investigative Site Manchester, United Kingdom, M20 9BX Less << |
NCT01473901 | Glioblastoma | Phase 1 | Completed | - | United States, Arkansas ... More >> Highlands Oncology Group Highlands Oncology Fayetteville, Arkansas, United States, 72703 United States, Massachusetts Dana Farber Cancer Institute SC (1) Boston, Massachusetts, United States, 02215 United States, Texas University of Texas/MD Anderson Cancer Center MD Anderson DeGrout Houston, Texas, United States, 77030-4009 Australia, Victoria Novartis Investigative Site Melbourne, Victoria, Australia, 3000 Canada, Ontario Novartis Investigative Site Hamilton, Ontario, Canada, L8V 5C2 Novartis Investigative Site Toronto, Ontario, Canada, M5G 1Z6 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Madrid, Spain, 28040 Less << |
NCT01634061 | Castration-resistant Prostate ... More >>Cancer Less << | Phase 1 | Completed | - | United States, California ... More >> Cedars Sinai Medical Center SC Los Angeles, California, United States, 90048 United States, New Jersey Hackensack University Medical Center Hackensack Univ Hackensack, New Jersey, United States, 07601 Belgium Novartis Investigative Site Brussels, Belgium, BE-B-1200 Novartis Investigative Site Wilrijk, Belgium, 2610 Canada, British Columbia Novartis Investigative Site Vancouver, British Columbia, Canada, V5Z 4E6 France Novartis Investigative Site Marseille, France, 13273 Novartis Investigative Site Villejuif Cedex, France, 94805 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08036 Novartis Investigative Site Madrid, Spain, 28041 United Kingdom Novartis Investigative Site Sutton, United Kingdom, SM2 5PT Less << |
NCT01304602 | Colorectal Cancer | Phase 1 | Completed | - | United States, Kansas ... More >> University of Kansas Cancer Center Kansas City, Kansas, United States, 66160 Less << |
NCT01790932 | Breast Cancer | PHASE2 | COMPLETED | 2025-09-15 | Dana-Farber Cancer Institute a... More >>t Faulkner Hospital, Boston, Massachusetts, 02130, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States|Brigham and Women's Hospital, Boston, Massachusetts, 02215, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States Less << |
NCT02000882 | Brain Metastases ... More >> Breast Cancer Metastatic Breast Cancer Less << | Phase 2 | Active, not recruiting | December 2018 | United States, Texas ... More >> Please contact Zuzanne Bristow for list of sites Multiple Locations, Texas, United States Less << |
NCT01629615 | Breast Cancer | PHASE2 | COMPLETED | 2025-10-15 | Dana-Farber at Faulkner Hospit... More >>al, Boston, Massachusetts, 02130, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Hospital Universitario Vall d′Hebron, Barcelona, 08035, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|Instituto Valenciano de Oncología, Valencia, 46009, Spain|Hospital Clínico Universitario de Valencia, Valencia, 46010, Spain Less << |
NCT01297491 | Non-small Cell Lung Cancer | PHASE2 | COMPLETED | 2025-10-14 | Ironwood Cancer and Research C... More >>enters SC, Chandler, Arizona, 85224, United States|Arizona Oncology Associates Tucson (Rudasill & La Cholla), Phoenix, Arizona, United States|Mayo Clinic - Arizona Mayo Scottsdale AZ, Scottsdale, Arizona, 85259, United States|Highlands Oncology Group Dept of Highlands Oncology Grp, Fayetteville, Arkansas, 72753, United States|Cedars Sinai Medical Center Dept.of Cedars-Sinai Med. Ctr., Los Angeles, California, 90048, United States|University of California at San Diego, Moores Cancer Ctr SC, San Diego, California, 92103, United States|University of Colorado Univ CO, Aurora, Colorado, 80045, United States|Rocky Mountain Cancer Centers Dept. of Rocky Mountain Cancer, Greenwood Village, Colorado, 80218, United States|H. Lee Moffitt Cancer Center & Research Institute H Lee Moffitt, Tampa, Florida, 33612, United States|Emory University School of Medicine/Winship Cancer Institute Emory 2, Atlanta, Georgia, 30322, United States|Rush University Medical Center SC, Chicago, Illinois, 60612, United States|University of Chicago Medical Center Unvi Chi, Chicago, Illinois, 60637, United States|University of Kansas Cancer Center Univ of KS, Kansas City, Kansas, 66160, United States|Massachusetts General Hospital Mass General, Boston, Massachusetts, 02114, United States|Fallon Clinic at Worcester Medical Center Fallon Clinic Worcester Med, Worcester, Massachusetts, 01608, United States|Karmanos Cancer Institute Wayne St Karmanos, Detroit, Michigan, 48201, United States|Washington University School of Medicine Washington University (16), St. Louis, Missouri, 63110, United States|Hematology Oncology Associates of Northern New Jersey PA DeptofHem-OncofNorthern NJ (2), Morristown, New Jersey, 07962, United States|Overlook Hospital - Carol G Simon Cancer Center Carol G Simon, Summit, New Jersey, 07901, United States|Roswell Park Cancer Institute Rosewell, Buffalo, New York, 14263, United States|Memorial Sloan Kettering Cancer Center Sloan Kettering, NY, New York, 90033, United States|Duke University Medical Center Duke 2, Durham, North Carolina, 27710, United States|MetroHealth Medical Center Dept.ofMetroHealthMedCtr.(2), Cleveland, Ohio, 44109-1998, United States|University of Oklahoma Health Sciences Center Dept. of Oklahoma Univ. HSC, Oklahoma City, Oklahoma, 73104, United States|Northwest Cancer Specialists Compass Oncology -BKM, Portland, Oregon, 97210, United States|University of Pittsburgh Medical Center SC-2, Pittsburgh, Pennsylvania, 15213, United States|Medical University of South Carolina MUSC, Charleston, South Carolina, 29425, United States|Baylor Health Care System/Sammons Cancer Center Baylor Texas Oncology, Dallas, Texas, 75246, United States|Texas Oncology South Texas Oncology, Dallas, Texas, 75251, United States|U of TX Southwestern Medical Center - SimmonsCompCancerCtr Clinical Research Office, Dallas, Texas, 75390-9151, United States|Virginia Oncology Associates VOA - Lake Wright (2), *see Various Departments*, Virginia, 23502, United States|University of Wisconsin Univ WIsc 2, Madison, Wisconsin, 53792, United States|Novartis Investigative Site, Rio Negro, Viedma, 8500, Argentina|Novartis Investigative Site, Buenos Aires, C1050AAK, Argentina|Novartis Investigative Site, Cordoba, X5002AOQ, Argentina|Novartis Investigative Site, Brussel, 1090, Belgium|Novartis Investigative Site, Charleroi, 6000, Belgium|Novartis Investigative Site, Genk, 3600, Belgium|Novartis Investigative Site, Leuven, 3000, Belgium|Novartis Investigative Site, Libramont, 6800, Belgium|Novartis Investigative Site, Salvador, BA, 41253-190, Brazil|Novartis Investigative Site, Rio de Janeiro, RJ, 20230-130, Brazil|Novartis Investigative Site, Florianopolis, SC, 88034-000, Brazil|Novartis Investigative Site, Barretos, SP, 14784-400, Brazil|Novartis Investigative Site, S?o Paulo, SP, 01246-000, Brazil|Novartis Investigative Site, Vancouver, British Columbia, V5Z 4E6, Canada|Novartis Investigative Site, Toronto, Ontario, M5G 1Z5, Canada|Novartis Investigative Site, Montreal, Quebec, H2X 3J4, Canada|Novartis Investigative Site, Caen Cedex, 14021, France|Novartis Investigative Site, Creteil, 94000, France|Novartis Investigative Site, Marseille cedex 20, 13915, France|Novartis Investigative Site, Rennes, F-35043, France|Novartis Investigative Site, Villejuif Cedex, 94805, France|Novartis Investigative Site, Berlin, 13125, Germany|Novartis Investigative Site, Essen, 45147, Germany|Novartis Investigative Site, Gauting, 82131, Germany|Novartis Investigative Site, Grosshansdorf, 22927, Germany|Novartis Investigative Site, Heidelberg, 69120, Germany|Novartis Investigative Site, Koeln, 51109, Germany|Novartis Investigative Site, Nuernberg, 90419, Germany|Novartis Investigative Site, Oldenburg, 26121, Germany|Novartis Investigative Site, Recklinghausen, 45657, Germany|Novartis Investigative Site, Hongkong, Hong Kong|Novartis Investigative Site, Budapest, 1121, Hungary|Novartis Investigative Site, Budapest, 1125, Hungary|Novartis Investigative Site, Deszk, 6772, Hungary|Novartis Investigative Site, Mátraháza, 3233, Hungary|Novartis Investigative Site, Szolnok, H-5000, Hungary|Novartis Investigative Site, Avellino, AV, 83100, Italy|Novartis Investigative Site, Genova, GE, 16132, Italy|Novartis Investigative Site, Milano, MI, 20133, Italy|Novartis Investigative Site, Milano, MI, 20141, Italy|Novartis Investigative Site, Parma, PR, 43100, Italy|Novartis Investigative Site, Udine, UD, 33100, Italy|Novartis Investigative Site, Kurashiki, Okayama, 710-8602, Japan|Novartis Investigative Site, Koto, Tokyo, 135-8550, Japan|Novartis Investigative Site, Maastricht, 6229 HX, Netherlands|Novartis Investigative Site, Singapore, 169610, Singapore|Novartis Investigative Site, Sabadell, Barcelona, 08208, Spain|Novartis Investigative Site, Barcelona, Catalunya, 08035, Spain|Novartis Investigative Site, Mataro, Catalu?a, 08301, Spain|Novartis Investigative Site, Alicante, Comunidad Valenciana, 03010, Spain|Novartis Investigative Site, Tainan 704, Taiwan ROC, 704, Taiwan|Novartis Investigative Site, Taipei, Taiwan ROC, 100, Taiwan|Novartis Investigative Site, Bangkok, 10700, Thailand|Novartis Investigative Site, Chiang Mai, 50200, Thailand|Novartis Investigative Site, Altunizade, 34662, Turkey|Novartis Investigative Site, Izmir, 35040, Turkey|Novartis Investigative Site, Northwood, Middlesex, HA6 2RN, United Kingdom|Novartis Investigative Site, Leicester, LE1 5WW, United Kingdom|Novartis Investigative Site, London, SE1 9RT, United Kingdom|Novartis Investigative Site, Manchester, M20 4BX, United Kingdom Less << |
NCT01830504 | Thyroid Cancers | PHASE2 | UNKNOWN | 2025-01-17 | Hospices Civils de Lyon, Lyon,... More >> 69003, France Less << |
NCT01737450 | Head and Neck Neoplasms|Neopla... More >>sm Metastasis|Recurrent Disease|Progressive Disease Less << | PHASE2 | COMPLETED | 2025-03-19 | Hopital St André, Bordeaux, Fr... More >>ance|H?pital BEAUJON, Clichy, France|Centre Oscar Lambret, Lille, France|Centre Léon Bérard, Lyon, France|Centre Val d'Aurelle - Paul Lamarque, Montpellier, France|Centre Antoine LACASSAGNE, Nice, France|Institut Curie, Paris, France|Centre Hospitalier Lyon Sud, Pierre Benite, 69003, France|Institut Gustave Roussy, Villejuif, France Less << |
NCT01953445 | Breast Neoplasms | Phase 2 | Withdrawn(The study sponsor fo... More >>und the trial to be not viable.) Less << | July 2015 | - |
NCT01613677 | Treatment for Metastatic or Lo... More >>cally Advanced Cervical Cancer Less << | PHASE2 | WITHDRAWN | 2025-09-17 | Novartis Investigative Site, R... More >>io de Janiero, RJ, 20231-050, Brazil Less << |
NCT01297452 | Solid Tumors | Phase 1 | Completed | - | United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less << |
NCT01806649 | Esophageal Cancer | PHASE2 | TERMINATED | 2016-04-30 | Songklanagarind Hospital, Prin... More >>ce of Songkla University, Hat yai, Songkhla, 90110, Thailand Less << |
NCT02404844 | Breast Cancer | Phase 2 | Completed | - | Germany ... More >> iOMEDICO AG Freiburg, Baden-Württemberg, Germany, 79108 Less << |
NCT02035124 | Advanced Prostate Cancer | Phase 2 | Withdrawn(Study withdrawn due ... More >>to slow accrual. No patients were enrolled.) Less << | - | United States, Florida ... More >> Florida Cancer Specialists-South Ft. Myers, Florida, United States, 33916 United States, Nebraska Nebraska Methodist Hospital Omaha, Nebraska, United States, 68114 United States, Tennessee Tennessee Oncology PLLC Nashville, Tennessee, United States, 37203 Less << |
NCT02194049 | Extensive Stage Small Cell Lun... More >>g Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << | Phase 1 | Completed | - | United States, California ... More >> University of California at Davis Cancer Center Sacramento, California, United States, 95817 Less << |
NCT01833169 | PI3K Pathway Activated Tumors | PHASE2 | COMPLETED | 2016-09-26 | Arizona Oncology Associates HO... More >>PE Division, Phoenix, Arizona, United States|Arizona Oncology Associates PC- HAL, Sedona, Arizona, 86336, United States|Highlands Oncology Group, Fayetteville, Arkansas, 72703, United States|Sarcoma Oncology Center, Santa Monica, California, 90403, United States|Rocky Mountain Cancer Centers RMCC - Aurora, Greenwood Village, Colorado, United States|Whittingham Cancer Center Norwalk Hospital, Norwalk, Connecticut, 06856, United States|Eastern Connecticut Hematology & Oncology Associates The Norwich Cancer Center, Norwich, Connecticut, 06360, United States|Florida Cancer Specialists Dept of Oncology (2), Fort Myers, Florida, 33901, United States|Florida Hospital Cancer Institute FL Hosp. Cancer Instit., Orlando, Florida, 32804, United States|Florida Cancer Specialists, West Palm Beach, Florida, 33401, United States|University Cancer & Blood Center, LLC, Athens, Georgia, 30607, United States|Southeastern Regional Medical Center, Newnan, Georgia, 30265, United States|Lurie Children's Hospital of Chicago Developmental Therapeutics, Chicago, Illinois, 60611, United States|Cancer Care Specialists of Central Illinois, Decatur, Illinois, 62526, United States|Illinois Cancer Care P.C. IL. Cancer Care, Peoria, Illinois, 61615-7828, United States|Illinois Cancer Care P.C., Peoria, Illinois, 61615-7828, United States|Cancer Treatment Centers of America Southwestern Regional Med. Ctr, Schaumburg, Illinois, 60173, United States|Northern Indiana Cancer Research Consortium No. Indiana Cancer Res., South Bend, Indiana, 46617, United States|University of Iowa Hospitals & Clinics Regulatory Contact 2, Iowa City, Iowa, 52242, United States|Eastern Maine Medical Center Research Center SC, Bangor, Maine, 04401, United States|Mount Auburn Hospital, Cambridge, Massachusetts, 02138, United States|Michigan Medicine University of Michigan Int. Medicine Oncology, Ann Arbor, Michigan, 48109 5271, United States|Cancer and Hematology Centers of West Michigan Dept. of Oncology, Grand Rapids, Michigan, 49546, United States|Minnesota Oncology Hematology, P.A. Minnesota Oncology Hematology, Minneapolis, Minnesota, 55404, United States|Nebraska Cancer Specialists Oncology Hematology West, Omaha, Nebraska, 68154, United States|Comprehensive Cancer Centers, Las Vegas, Nevada, 89169, United States|Hematology Oncology Associates of Northern New Jersey PA Regional Cancer Care Assoc., Morristown, New Jersey, 07962, United States|Cancer Center at Presbyterian, Albuquerque, New Mexico, United States|New York Oncology Hematology NY Onc Hem, Albany, New York, 12208, United States|Waverly Hematology Oncology, Cary, North Carolina, 27518, United States|University of N C at Chapel Hill Physician Office Building, Chapel Hill, North Carolina, 27599-7600, United States|Duke University Medical Center Seeley G. Mudd Bldg., Durham, North Carolina, 27710, United States|Cleveland Clinic Foundation Cleveland Clinic (19), Cleveland, Ohio, 44195, United States|Mid Ohio Oncology/Hematology Mark H. Zangmeister Center, Columbus, Ohio, 43219, United States|Bend Memorial Clinic Bend Mem. Clinic, Bend, Oregon, 97701, United States|Northwest Cancer Specialists Compass Oncology (36), Portland, Oregon, 97210, United States|Oregon Health and Science University Oregon Health & Science U (56), Portland, Oregon, 97239, United States|Salem Health, Salem, Oregon, 97309, United States|Gettysburg Cancer Center, Gettysburg, Pennsylvania, 17325, United States|West Penn Allegheny Oncology Network, Natrona Heights, Pennsylvania, 15065, United States|University of Pittsburgh Medical Center UPMC, Pittsburgh, Pennsylvania, 15213, United States|Abington Hematology Oncology Associates, Inc Abington Hem Onc Assoc (5), Willow Grove, Pennsylvania, 19090, United States|Sanford University of South Dakota Medical Center Sanford Health, Sioux Falls, South Dakota, 57104, United States|Chattanooga Oncology and Hematology Assoicates, PC Chattanooga Oncology, Chattanooga, Tennessee, 37404, United States|West Cancer Clinic, Memphis, Tennessee, 38120, United States|Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|Texas Oncology P A Round Rock, Dallas, Texas, 75251, United States|Texas Oncology Sammons Cancer Center Sammons Cancer Center (10), Dallas, Texas, 78246, United States|Texas Oncology, P.A. Texas Oncololgy, P.A. (8), Fort Worth, Texas, 76104, United States|Oncology Consultants Oncology Group, Houston, Texas, 77024, United States|MD Anderson Cancer Center/University of Texas MD Anderson Cancer Center (3), Houston, Texas, 77030, United States|Cancer Care Centers of South Texas HOAST CCC of So. TX-San Antonio (3), San Antonio, Texas, 78229, United States|Tyler Cancer Center, Tyler, Texas, 75702, United States|Intermountain Medical Center Intermountain Healthcare, Murray, Utah, 84157, United States|Virginia Cancer Specialists Virginia Cancer Specialists, Fairfax, Virginia, 22031, United States|Blue Ridge Research Center at Roanoke Neurological Center McKesson Specialty Care, Roanoke, Virginia, 24018, United States|Kadlec Clinic Hematology and Oncology Kadlec Clinic Hematology & Onc, Kennewick, Washington, 99336, United States|Northwest Medical Specialties Hematology/Oncology, Tacoma, Washington, 98405, United States|Medical College of Wisconsin Cancer Center, Milwaukee, Wisconsin, 53226, United States Less << |
NCT01396499 | Leukemia | PHASE1 | COMPLETED | 2025-10-16 | University of Texas MD Anderso... More >>n Cancer Center, Houston, Texas, 77030, United States Less << |
NCT01591421 | Metastatic Colorectal Cancer | Phase 1 Phase 2 | Active, not recruiting | December 2018 | Canada, British Columbia ... More >> BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Ontario Ottawa Hospital Research Institute Ottawa, Ontario, Canada, K1H 8L6 Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less << |
NCT02301364 | Lymphoma Prim... More >>ary Central Nervous System Lymphoma Recurrent/Refractory Secondary Central Nervous System Lymphoma Less << | Phase 2 | Completed | - | United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering West Harrison Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less << |
NCT01623349 | Ovarian Cancer ... More >> Breast Cancer Less << | Phase 1 | Active, not recruiting | December 2019 | United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77230 Less << |
NCT01833169 | PI3K Pathway Activated Tumors | PHASE2 | COMPLETED | 2016-09-26 | Arizona Oncology Associates HO... More >>PE Division, Phoenix, Arizona, United States|Arizona Oncology Associates PC- HAL, Sedona, Arizona, 86336, United States|Highlands Oncology Group, Fayetteville, Arkansas, 72703, United States|Sarcoma Oncology Center, Santa Monica, California, 90403, United States|Rocky Mountain Cancer Centers RMCC - Aurora, Greenwood Village, Colorado, United States|Whittingham Cancer Center Norwalk Hospital, Norwalk, Connecticut, 06856, United States|Eastern Connecticut Hematology & Oncology Associates The Norwich Cancer Center, Norwich, Connecticut, 06360, United States|Florida Cancer Specialists Dept of Oncology (2), Fort Myers, Florida, 33901, United States|Florida Hospital Cancer Institute FL Hosp. Cancer Instit., Orlando, Florida, 32804, United States|Florida Cancer Specialists, West Palm Beach, Florida, 33401, United States|University Cancer & Blood Center, LLC, Athens, Georgia, 30607, United States|Southeastern Regional Medical Center, Newnan, Georgia, 30265, United States|Lurie Children's Hospital of Chicago Developmental Therapeutics, Chicago, Illinois, 60611, United States|Cancer Care Specialists of Central Illinois, Decatur, Illinois, 62526, United States|Illinois Cancer Care P.C. IL. Cancer Care, Peoria, Illinois, 61615-7828, United States|Illinois Cancer Care P.C., Peoria, Illinois, 61615-7828, United States|Cancer Treatment Centers of America Southwestern Regional Med. Ctr, Schaumburg, Illinois, 60173, United States|Northern Indiana Cancer Research Consortium No. Indiana Cancer Res., South Bend, Indiana, 46617, United States|University of Iowa Hospitals & Clinics Regulatory Contact 2, Iowa City, Iowa, 52242, United States|Eastern Maine Medical Center Research Center SC, Bangor, Maine, 04401, United States|Mount Auburn Hospital, Cambridge, Massachusetts, 02138, United States|Michigan Medicine University of Michigan Int. Medicine Oncology, Ann Arbor, Michigan, 48109 5271, United States|Cancer and Hematology Centers of West Michigan Dept. of Oncology, Grand Rapids, Michigan, 49546, United States|Minnesota Oncology Hematology, P.A. Minnesota Oncology Hematology, Minneapolis, Minnesota, 55404, United States|Nebraska Cancer Specialists Oncology Hematology West, Omaha, Nebraska, 68154, United States|Comprehensive Cancer Centers, Las Vegas, Nevada, 89169, United States|Hematology Oncology Associates of Northern New Jersey PA Regional Cancer Care Assoc., Morristown, New Jersey, 07962, United States|Cancer Center at Presbyterian, Albuquerque, New Mexico, United States|New York Oncology Hematology NY Onc Hem, Albany, New York, 12208, United States|Waverly Hematology Oncology, Cary, North Carolina, 27518, United States|University of N C at Chapel Hill Physician Office Building, Chapel Hill, North Carolina, 27599-7600, United States|Duke University Medical Center Seeley G. Mudd Bldg., Durham, North Carolina, 27710, United States|Cleveland Clinic Foundation Cleveland Clinic (19), Cleveland, Ohio, 44195, United States|Mid Ohio Oncology/Hematology Mark H. Zangmeister Center, Columbus, Ohio, 43219, United States|Bend Memorial Clinic Bend Mem. Clinic, Bend, Oregon, 97701, United States|Northwest Cancer Specialists Compass Oncology (36), Portland, Oregon, 97210, United States|Oregon Health and Science University Oregon Health & Science U (56), Portland, Oregon, 97239, United States|Salem Health, Salem, Oregon, 97309, United States|Gettysburg Cancer Center, Gettysburg, Pennsylvania, 17325, United States|West Penn Allegheny Oncology Network, Natrona Heights, Pennsylvania, 15065, United States|University of Pittsburgh Medical Center UPMC, Pittsburgh, Pennsylvania, 15213, United States|Abington Hematology Oncology Associates, Inc Abington Hem Onc Assoc (5), Willow Grove, Pennsylvania, 19090, United States|Sanford University of South Dakota Medical Center Sanford Health, Sioux Falls, South Dakota, 57104, United States|Chattanooga Oncology and Hematology Assoicates, PC Chattanooga Oncology, Chattanooga, Tennessee, 37404, United States|West Cancer Clinic, Memphis, Tennessee, 38120, United States|Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|Texas Oncology P A Round Rock, Dallas, Texas, 75251, United States|Texas Oncology Sammons Cancer Center Sammons Cancer Center (10), Dallas, Texas, 78246, United States|Texas Oncology, P.A. Texas Oncololgy, P.A. (8), Fort Worth, Texas, 76104, United States|Oncology Consultants Oncology Group, Houston, Texas, 77024, United States|MD Anderson Cancer Center/University of Texas MD Anderson Cancer Center (3), Houston, Texas, 77030, United States|Cancer Care Centers of South Texas HOAST CCC of So. TX-San Antonio (3), San Antonio, Texas, 78229, United States|Tyler Cancer Center, Tyler, Texas, 75702, United States|Intermountain Medical Center Intermountain Healthcare, Murray, Utah, 84157, United States|Virginia Cancer Specialists Virginia Cancer Specialists, Fairfax, Virginia, 22031, United States|Blue Ridge Research Center at Roanoke Neurological Center McKesson Specialty Care, Roanoke, Virginia, 24018, United States|Kadlec Clinic Hematology and Oncology Kadlec Clinic Hematology & Onc, Kennewick, Washington, 99336, United States|Northwest Medical Specialties Hematology/Oncology, Tacoma, Washington, 98405, United States|Medical College of Wisconsin Cancer Center, Milwaukee, Wisconsin, 53226, United States Less << |
NCT01852292 | Head and Neck Squamous Cell Ca... More >>rcinoma Less << | Phase 2 | Terminated | - | - |
NCT01852292 | - | Terminated | - | - | |
NCT01870726 | c-MET Inhibitor; PI3K Inhibito... More >>r, PTEN Mutations, Homozygous Del. of PTEN or PTEN Neg. by IHC, c-Met Ampli. by FISH, INC280, BKM120, Buparlisib; Recurrent GBM Less << | Phase 1 Phase 2 | Terminated | - | United States, Massachusetts ... More >> Dana Farber Cancer Institute SC Boston, Massachusetts, United States, 02215 United States, New York Columbia University Medical Center- New York Presbyterian Dept of Oncology New York, New York, United States, 10032 Memorial Sloan Kettering Cancer Center Neurology New York, New York, United States, 90033 United States, North Carolina Duke University Medical Center Duke - Baker Durham, North Carolina, United States, 27710 United States, Texas University of Texas MD Anderson Cancer Center SC-3 Houston, Texas, United States, 77030 Germany Novartis Investigative Site Bonn, Germany, 53105 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Tübingen, Germany, 72076 Netherlands ErasmusMC Cancer Institute - Neurooncology, RM G3-55 Rotterdam, Netherlands, 3075EA University Medical Center Utrecht, Rm Q05.4.300, P.O. Box 85500 Utrecht, Netherlands, 3508 GA Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Madrid, Spain, 28041 Switzerland Novartis Investigative Site St. Gallen, Switzerland, 9007 Less << |
NCT02301364 | - | Completed | - | - | |
NCT01870726 | - | Terminated | - | - | |
NCT01527877 | Head Neck Cancer Squamous Cell... More >> Metastatic|Head Neck Cancer Squamous Cell Recurrent Less << | PHASE2 | UNKNOWN | 2025-08-14 | Severance Hospital, Seoul, Kor... More >>ea, Republic of Less << |
NCT01571024 | Advanced Solid Tumors ... More >> Metastatic Colorectal Cancer Metastatic Pancreatic Cancer Less << | Phase 1 | Completed | - | United States, North Carolina ... More >> University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 Less << |
NCT01349660 | - | Active, not recruiting | - | - | |
NCT01487265 | Non Small Cell Lung Cancer | Phase 2 | Active, not recruiting | December 2017 | United States, Florida ... More >> Florida Cancer Specialists South Fort Myers, Florida, United States, 33916 Florida Hospital Cancer Institute Orlando, Florida, United States, 32804 Florida Cancer Specialists North Saint Petersburg, Florida, United States, 33705 Florida Cancer Specialists East West Palm Beach, Florida, United States, 33401 United States, Ohio Oncology Hematology Care, Inc. Cincinnati, Ohio, United States, 45242 United States, Tennessee Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 United States, Texas Center for Cancer and Blood Disorders Fort Worth, Texas, United States, 76104 Less << |
NCT01513356 | Breast Cancer | EARLY_PHASE1 | COMPLETED | 2025-02-14 | Hospital Madrid Norte Sanchina... More >>rro- CIOCC, Madrid, 28050, Spain Less << |
NCT01589861 | Breast Cancer | Phase 1 Phase 2 | Suspended(Data analysis) | January 2018 | France ... More >> Institut Paoli-Calmettes Marseille, France, 13008 Less << |
NCT01487265 | - | Active, not recruiting | - | - | |
NCT01349660 | Glioblastoma Multiforme | Phase 1 Phase 2 | Active, not recruiting | February 2018 | United States, Connecticut ... More >> Yale School of Medicine New Haven, Connecticut, United States, 06520 United States, Florida Florida Cancer Specialists Fort Myers, Florida, United States, 33916 Florida Hospital Cancer Institute Orlando, Florida, United States, 32804 Florida Cancer Specialists Saint Petersburg, Florida, United States, 33705 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Michigan Grand Rapids Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Nebraska Nebraska Methodist Hospital Omaha, Nebraska, United States, 68114 United States, Tennessee Tennessee Oncology Nashville, Tennessee, United States, 37203 Less << |
NCT01695473 | High Risk Prostate Cancer | PHASE2 | TERMINATED | 2015-02-05 | University of California, San ... More >>Francisco, San Francisco, California, 94143, United States Less << |
NCT01385293 | Prostate Cancer|Metastatic (Sp... More >>read to Other Areas of the Body) Less << | PHASE2 | TERMINATED | 2025-02-16 | Duke Cancer Institute, Durham,... More >> North Carolina, 27710, United States|OHSU Knight Cancer Institute, Portland, Oregon, 97239, United States|University of Washington, Seattle, Washington, 98109, United States Less << |
NCT01385293 | Prostate Cancer|Metastatic (Sp... More >>read to Other Areas of the Body) Less << | PHASE2 | TERMINATED | 2025-02-16 | Duke Cancer Institute, Durham,... More >> North Carolina, 27710, United States|OHSU Knight Cancer Institute, Portland, Oregon, 97239, United States|University of Washington, Seattle, Washington, 98109, United States Less << |
NCT02439489 | Solid Tumors | Phase 1 | Completed | - | Italy ... More >> Ospedale San Raffaele Milano, MI, Italy, 20100 Less << |
NCT01550380 | Endometrial Cancer | PHASE2 | WITHDRAWN | 2025-07-14 | Huntsman Cancer Institute, Sal... More >>t Lake City, Utah, 84112, United States Less << |
NCT02113878 | Carcinoma, Squamous Cell of He... More >>ad and Neck HPV Positive Oropharyngeal Squamous Cell Carcinoma Hypopharyngeal Cancer Early Invasive Cervical Squamous Cell Carcinoma Carcinoma of Larynx Cancer of Nasopharynx Less << | Phase 1 | Active, not recruiting | March 2020 | United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less << |
NCT01283048 | Renal Cell Carcinoma | Phase 1 | Completed | - | United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Michigan Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 Less << |
NCT02128724 | Carcinoma, Non-Small-Cell Lung | PHASE1 | COMPLETED | 2017-10-17 | Churchill Hospital, Oxford, Ox... More >>on, OX3 7LE, United Kingdom Less << |
NCT01570296 | Non-Small Cell Lung Cancer ... More >> Solid Tumors Less << | Phase 1 | Active, not recruiting | April 2019 | Singapore ... More >> National Cancer Centre Singapore Singapore, Singapore, 169610 Less << |
NCT02487823 | Non Castrate Metastatic Prosta... More >>te Cancer Less << | Phase 1 | Terminated(Defect of recruitme... More >>nt) Less << | - | France ... More >> Institut Paoli Calmettes Marseille, France, 13009 Less << |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.44mL 0.49mL 0.24mL |
12.18mL 2.44mL 1.22mL |
24.37mL 4.87mL 2.44mL |